DA MONICA CANNON: Open Payments
NPI 1063028793 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,543 in 66 payments from 19 companies in 2025. Trend: 2023 $1,629 · 2024 $1,982 · 2025 $2,543
Food & beverage: $2,543
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $323 |
| AstraZeneca Pharmaceuticals LP | 7 | $306 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $271 |
| Phathom Pharmaceuticals, Inc. | 2 | $253 |
| SANOFI-AVENTIS U.S. LLC | 2 | $201 |
| Vanda Pharmaceuticals Inc. | 2 | $183 |
| Novo Nordisk Inc | 18 | $183 |
| Lilly USA, LLC | 7 | $152 |
| E.R. Squibb & Sons, L.L.C. | 1 | $126 |
| Alkermes, Inc. | 1 | $125 |
Products named: VRAYLAR, CAPLYTA, VOQUEZNA, TZIELD, FANAPT, COBENFY, LYBALVI, BREZTRI.
Industry payments across GA — which companies pay providers there.
